查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828156

2025年全球灌注系统市场报告

Perfusion Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，灌注系统市场经历了强劲成长，市场规模从2024年的13.3亿美元成长到2025年的14.5亿美元，复合年增长率为9.1%。这段历史时期的成长归功于灌注科学的基础研究、低温技术的引入、心肺体外迴圈的出现、体外循环的早期发展。

预计未来几年灌注系统市场规模将快速成长，到2029年将达到21.5亿美元，复合年增长率为10.4%。预测期内的成长动力包括：对患者预后的关注度不断提高、心血管手术数量增加、微创手术的扩展、体外膜氧合（ECMO）的使用率不断提高、全球医疗基础设施建设以及老年人口的增长。预测期内的主要趋势包括：可携式和紧凑型设计、自动化和机器人技术的整合、远端监控和远端医疗、模组化和可自订平台、高级数据分析以及人工智慧。

灌注系统是重要的医疗设备，用于在需要心臟暂时停止运作的外科手术过程中维持患者的血液循环和氧气供应。它们主要用于需要临时器官支持的心血管手术和器官移植，并在维持生理稳定性方面发挥至关重要的作用。

心肺灌注系统种类繁多，包括心肺灌注系统、体外膜肺氧合 (ECMO)、离体器官灌注系统以及各种特殊类型的系统。心肺灌注系统可暂时取代心臟和肺的功能，尤其是在心血管手术期间。这些系统可容纳各种器官，包括心臟、肺、肾臟和肝臟，并使用低温和恆温等技术。其应用范围涵盖各种医疗保健机构，包括医院、诊所、门诊手术中心和其他各种医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供灌注系统市场统计数据，包括全球灌注系统行业规模、各地区市场份额、竞争对手的市场份额、详细的灌注系统细分市场、市场趋势和商机，以及您在灌注系统行业取得成功所需的数据。本灌注系统市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长10.4%，较先前预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这种影响将直接影响美国，导致主要从英国和丹麦进口的热交换器和血气监测感测器成本上升，并可能影响器官移植和心血管手术的结果。由于互惠关税以及不断升级的贸易紧张局势和限制对全球经济和贸易造成的负面影响，这种影响也将更加广泛。

器官移植的快速成长是灌注系统市场预期成长的关键驱动力。器官移植是指透过手术将患病或受损的器官从捐赠者转移到面临器官衰竭或疾病的接受者。灌注系统在这过程中发挥着至关重要的作用，它能够保存和运输器官，并确保其在移植过程中的活力。值得注意的是，美国器官采购和移植网络 (ORTPN) 2021 年 1 月的数据显示，美国器官移植数量年增 5.9%，达到 41,354 例。这一增长证实了对成功器官移植的需求不断增长，从而推动了灌注系统市场的发展。

预计未来几年老龄化人口的成长将成为灌注系统市场扩张的驱动力。老龄化社会的特征是 65 岁及以上人口比例不断增加，这通常与可导致器官衰竭的老龄化相关疾病的增加有关。灌注系统在器官移植中起着至关重要的作用，它负责保存器官并将其从捐赠者运送到接受者。这些系统旨在维持人类体外的器官活力，进而增加移植成功的机会。例如，负责全球公共卫生的联合国专门机构世界卫生组织 (WHO) 预测，到 2030 年，世界上大约六分之一的人将年满 60 岁或以上。此外，预计到 2050 年，全球 60 岁或以上人口将翻一番，达到 21 亿。因此，老化人口的成长正在推动灌注系统市场的成长。

产品创新是灌注系统市场的一大趋势。新兴市场先锋企业正专注于开发创新解决方案，以巩固其市场地位。 LivaNova 于 2023 年 2 月在欧洲推出的 Essenz 灌注系统就是一个例子。该系统以其紧凑、模组化和可携式的设计而闻名，是一款专为心血管手术心肺体外迴圈(CPB) 系统。其模组化设计使其能够根据不同的患者需求和手术程序进行定制，使其在临床环境中具有高度的通用性。

灌注系统市场的主要企业正致力于开发创新产品，以提高临床效率和患者照护，特别是在心肺体外迴圈(CPB) 手术期间。一个显着的例子是 Essenz 患者监护仪，它具有中央显示屏，可持续显示关键患者参数，从而实现量身定制的管理策略。 2022 年 4 月，英国医疗技术创新者 LivaNova PLC 宣布 Essenz 患者监视器获得监管部门核准并有针对性地进行商业发布。这种先进的监护系统采用以患者为中心的方法，以提高 CPB 手术期间的临床效率和护理品质。它获得了美国食品药物管理局(FDA) 的 510(k) 许可和 CE 标誌，并已在参与以用户为中心的设计计划的美国和欧洲部分医院首次推出。 Essenz 患者监视器增强了负责人在整个 CPB 手术过程中的决策能力，并且与 LivaNova S5 体外循环机完全相容。这项技术创新反映了透过先进的监护技术改善心血管手术结果的更广泛趋势。

2022年12月，美国知名製药公司默克公司（Merck & Co. Inc.）完成了对Erbi Biosystems的收购，收购金额未揭露。此次策略性收购旨在加速开发可扩展的细胞灌註生物反应器工艺，起始工艺最低可达2毫升。此次收购将显着增强默克在治疗性蛋白质领域的上游产品组合。製程解决方案业务部与生命科学服务部共同构成默克「三大」业务驱动力，占据着举足轻重的地位。 Erbi Biosystems的整合符合默克致力于推动该业务部创新的承诺。 Erbi Biosystems是一家总部位于美国的生技工具公司。

灌注系统市场的主要企业包括 Getinge AB、Medtronic plc、LivaNova PLC、Terumo Corporation、Lifeline Scientific Inc.、XVIVO Perfusion AB、Repligen Corporation、Spectrum Laboratories Inc.、Merck KGaA、Harvard Bioscience Inc.、 ScientificGE Instruments Inc. COMPANY、Organ Assist Products BV、Hitachi, Ltd.、Bioptechs Inc.、Cytiva Company、Sorin Group、Organ Recovery Systems Inc.、TransMedics Inc.、Paragonix Technologies Inc.、Bridge to Life (Europe) Ltd.、OrganOx Limited 和 Preservation Solutions Inc.

2024 年，北美是灌注系统市场中最大的地区。灌注系统市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

灌注系统市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

灌注系统市场由提供器官移植服务、血液管理服务、细胞分离护理以及心臟和呼吸外科手术服务的营业单位所获得的收益所构成。市场价值包括服务提供者销售或包含在其服务产品中的相关商品的价值。灌注系统市场还包括用于提供灌注系统相关服务的氧合器、管道和过滤设备的销售。该市场的价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球灌注系统：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球灌注系统市场：成长率分析
  • 全球灌注系统市场表现：规模与成长，2019-2024
  • 全球灌注系统市场预测：规模与成长，2024-2029年，2034年
  • 全球灌注系统：总目标市场（TAM）

第六章 市场细分

  • 全球灌注系统市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 心肺灌注系统
  • 体外膜氧合（ECMO）
  • 独立器官灌注系统
  • 其他产品
  • 全球灌注系统市场（依器官类型）：2019-2024 年、2024-2029 年、2034 年表现及预测
  • 心
  • 肺
  • 肾
  • 肝
  • 其他器官类型
  • 全球灌注系统市场技术、效能及预测（2019-2024、2024-2029、2034）
  • 低温
  • 正常体温
  • 全球灌注系统市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他最终用户
  • 全球灌注系统市场：心肺灌注系统的细分（按类型）、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 心肺机
  • 血泵
  • 氧合设备
  • 全球灌注系统市场：按体外膜氧合 (ECMO) 细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 静脉-动脉 (VA) ECMO 系统
  • 静脉-静脉 (VV) ECMO 系统
  • 可携式ECMO系统
  • 全球灌注系统市场：独立器官灌注系统的细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 肝臟灌注系统
  • 肾臟灌注系统
  • 心臟灌注系统
  • 全球灌注系统市场：按产品类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 血管插管
  • 热交换器
  • 灌注监测系统

第七章 区域和国家分析

  • 全球灌注系统市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球灌注系统市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 灌注系统市场：竞争格局
  • 灌注系统市场：公司简介
    • Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Lifeline Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • XVIVO Perfusion AB
  • Repligen Corporation
  • Spectrum Laboratories Inc.
  • Merck KGaA
  • Harvard Bioscience Inc.
  • ALA Scientific Instruments Inc.
  • XENIOS AG
  • Siemens Healthcare Private Limited
  • Shimadzu Corporation
  • GENERAL ELECTRIC COMPANY
  • Organ Assist Products BV
  • Hitachi Ltd.
  • Bioptechs Inc.
  • Cytiva Company
  • Sorin Group

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年灌注系统市场：提供新机会的国家
  • 2029年灌注系统市场：细分市场带来新机会
  • 2029年灌注系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24402u

Perfusion systems encompass vital medical devices employed to sustain blood circulation and oxygenation in patients during surgical procedures necessitating a temporary pause in the heart's normal function. Primarily utilized in cardiac surgeries, organ transplants, and other procedures requiring temporary organ function support, these systems play a critical role in maintaining physiological stability.

They come in various types, including cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and specialized variations. Cardiopulmonary perfusion systems specifically substitute the heart and lung functions temporarily during cardiac surgeries. These systems cater to diverse organs such as the heart, lungs, kidneys, liver, and others, employing techniques such as hypothermic and normothermic approaches. Their applications span across different healthcare settings, including hospitals, clinics, ambulatory surgical centers, and various other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The perfusion systems market research report is one of a series of new reports from The Business Research Company that provides perfusion systems market statistics, including perfusion systems industry global market size, regional shares, competitors with a perfusion systems market share, detailed perfusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion systems industry. This perfusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The perfusion systems market size has grown strongly in recent years. It will grow from $1.33 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to the foundational research in perfusion science, the introduction of hypothermia techniques, the inception of cardiopulmonary bypass, and early heart-lung machine development.

The perfusion systems market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to a focus on patient outcomes, a rise in cardiovascular surgeries, expansion of minimally invasive procedures, increased ECMO usage, global healthcare infrastructure development, and growing geriatric population. Major trends in the forecast period include portable and compact designs, automation and robotics integration, remote monitoring and telemedicine, modular and customizable platforms, advanced data analytics, and AI.

The forecast of 10.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for heat exchanger units and blood gas monitoring sensors, largely imported from the UK and Denmark, affecting organ transplant and cardiac surgery outcomes.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in organ transplants stands as a significant driving force behind the anticipated growth of the perfusion systems market. Organ transplants involve the surgical transfer of diseased or damaged organs from donors to recipients facing organ failure or disease. Perfusion systems play a vital role in this process by preserving and transporting organs, ensuring their viability during transplantation. Notably, data from the Organ Procurement and Transplantation Network in January 2021 indicated a 5.9% increase in organ transplants in the US, totaling 41,354 procedures, compared to the previous year. This uptick underscores the escalating demand driving the perfusion systems market due to the rising need for successful organ transplants.

The growing aging population is anticipated to drive the expansion of the perfusion systems market in the coming years. An aging population is characterized by a larger percentage of individuals aged 65 and older, which often correlates with a rise in age-related diseases that can lead to organ failure. Perfusion systems play a crucial role in organ transplantation by preserving and transporting organs from donors to recipients. These systems are designed to maintain organ viability outside the human body, thereby enhancing the likelihood of successful transplants. For example, the World Health Organization, a specialized agency of the United Nations focused on global public health, projects that by 2030, approximately 1 in 6 people worldwide will be 60 years or older. Additionally, the global population of individuals aged 60 and above is expected to double to 2.1 billion by 2050. Consequently, the increasing aging population is propelling the growth of the perfusion systems market.

Product innovation emerges as a prominent trend within the perfusion systems market. Leading market players are channeling efforts into developing innovative solutions to fortify their market positions. An instance is LivaNova's February 2023 launch of the Essenz perfusion system in Europe. This system, known for its compact, modular, and portable design, is a cardiopulmonary bypass (CPB) system tailored for cardiac surgeries. Its modularity allows customization for diverse patient needs and surgical procedures, facilitating its versatility across clinical settings.

Major companies in the perfusion systems market are focusing on developing innovative products to enhance clinical efficiency and patient care, particularly during cardiopulmonary bypass (CPB) procedures. A notable example is the Essenz Patient Monitor, which features a centralized display that continuously shows critical patient parameters, enabling tailored management strategies. In April 2022, LivaNova PLC, a UK-based medical technology and innovation company, announced the regulatory approvals and targeted commercial launch of the Essenz Patient Monitor. This advanced monitoring system adopts a patient-centered approach to improve clinical efficiency and care quality during CPB procedures. It received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark, leading to its initial launch in select hospitals across the U.S. and Europe that participated in the user-centric design program. The Essenz Patient Monitor enhances decision-making for perfusionists throughout the CPB procedure and is fully compatible with the LivaNova S5 heart-lung machine. Such innovations reflect a broader trend toward improving outcomes in cardiac surgeries through advanced monitoring technologies.

In December 2022, Merck & Co Inc., a prominent US-based pharmaceutical company, finalized the acquisition of Erbi Biosystems Inc. for an undisclosed sum. This strategic acquisition aims to facilitate the development of scalable cell-based perfusion bioreactor processes, initiating from as little as 2 ml. This move significantly strengthens Merck's upstream portfolio concerning therapeutic proteins. Among Merck's key growth drivers-referred to as its "Big 3," alongside the Life Science Services business unit, the Process Solutions business unit holds pivotal significance. The integration of Erbi Biosystems aligns with Merck's commitment to driving innovation within this specific business unit. Notably, Erbi Biosystems Inc. is a biotechnology tools company based in the United States.

Major companies operating in the perfusion systems market include Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Lifeline Scientific Inc., XVIVO Perfusion AB, Repligen Corporation, Spectrum Laboratories Inc., Merck KGaA, Harvard Bioscience Inc., ALA Scientific Instruments Inc., XENIOS AG, Siemens Healthcare Private Limited Shimadzu Corporation, GENERAL ELECTRIC COMPANY, Organ Assist Products B.V., Hitachi Ltd., Bioptechs Inc., Cytiva Company, Sorin Group, Organ Recovery Systems Inc., TransMedics Inc., Paragonix Technologies Inc., Bridge to Life (Europe) Ltd., OrganOx Limited, Preservation Solutions Inc.

North America was the largest region in the perfusion systems market in 2024. The regions covered in the perfusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the perfusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The perfusion systems market consists of revenues earned by entities by providing organ transplantation service, blood management services, cell isolation care, cardiac and respiratory disorders surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion systems market also includes sales of oxygenators, tubing, and filters equipment which are used in providing perfusion systems related services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Perfusion Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on perfusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for perfusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The perfusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Cardiopulmonary Perfusion System; Extracorporeal membrane oxygenation (ECMO); Isolated Organ Perfusion Systems; Other Products
  • 2) By Type Of Organ: Heart; Lung; Kidney; Liver; Other Type Of Organs
  • 3) By Technique: Hypothermic; Normothermic
  • 4) By End-User: Hospital; Clinic; Ambulatory Surgical Centers; Other End-users
  • Subsegments:
  • 1) By Cardiopulmonary Perfusion System: Heart-Lung Machines; Blood Pumps; Oxygenators
  • 2) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Arterial (VA) ECMO Systems; Veno-Venous (VV) ECMO Systems; Portable ECMO Systems
  • 3) By Isolated Organ Perfusion Systems: Liver Perfusion Systems; Kidney Perfusion Systems; Heart Perfusion Systems
  • 4) By Other Products: Vascular Cannulae; Heat Exchangers; Perfusion Monitoring Systems
  • Companies Mentioned: Getinge AB; Medtronic plc; LivaNova PLC; Terumo Corporation; Lifeline Scientific Inc.; XVIVO Perfusion AB; Repligen Corporation; Spectrum Laboratories Inc.; Merck KGaA; Harvard Bioscience Inc.; ALA Scientific Instruments Inc.; XENIOS AG; Siemens Healthcare Private Limited Shimadzu Corporation; GENERAL ELECTRIC COMPANY; Organ Assist Products B.V.; Hitachi Ltd.; Bioptechs Inc.; Cytiva Company; Sorin Group; Organ Recovery Systems Inc.; TransMedics Inc.; Paragonix Technologies Inc.; Bridge to Life (Europe) Ltd.; OrganOx Limited; Preservation Solutions Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Perfusion Systems Market Characteristics

3. Perfusion Systems Market Trends And Strategies

4. Perfusion Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Perfusion Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Perfusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Perfusion Systems Market Growth Rate Analysis
  • 5.4. Global Perfusion Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Perfusion Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Perfusion Systems Total Addressable Market (TAM)

6. Perfusion Systems Market Segmentation

  • 6.1. Global Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiopulmonary Perfusion System
  • Extracorporeal membrane oxygenation (ECMO)
  • Isolated Organ Perfusion Systems
  • Other Products
  • 6.2. Global Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart
  • Lung
  • Kidney
  • Liver
  • Other Type Of Organs
  • 6.3. Global Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypothermic
  • Normothermic
  • 6.4. Global Perfusion Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Clinic
  • Ambulatory Surgical Centers
  • Other End-users
  • 6.5. Global Perfusion Systems Market, Sub-Segmentation Of Cardiopulmonary Perfusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart-Lung Machines
  • Blood Pumps
  • Oxygenators
  • 6.6. Global Perfusion Systems Market, Sub-Segmentation Of Extracorporeal Membrane Oxygenation (ECMO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Veno-Arterial (VA) ECMO Systems
  • Veno-Venous (VV) ECMO Systems
  • Portable ECMO Systems
  • 6.7. Global Perfusion Systems Market, Sub-Segmentation Of Isolated Organ Perfusion Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Perfusion Systems
  • Kidney Perfusion Systems
  • Heart Perfusion Systems
  • 6.8. Global Perfusion Systems Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vascular Cannulae
  • Heat Exchangers
  • Perfusion Monitoring Systems

7. Perfusion Systems Market Regional And Country Analysis

  • 7.1. Global Perfusion Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Perfusion Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Perfusion Systems Market

  • 8.1. Asia-Pacific Perfusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Perfusion Systems Market

  • 9.1. China Perfusion Systems Market Overview
  • 9.2. China Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Perfusion Systems Market

  • 10.1. India Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Perfusion Systems Market

  • 11.1. Japan Perfusion Systems Market Overview
  • 11.2. Japan Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Perfusion Systems Market

  • 12.1. Australia Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Perfusion Systems Market

  • 13.1. Indonesia Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Perfusion Systems Market

  • 14.1. South Korea Perfusion Systems Market Overview
  • 14.2. South Korea Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Perfusion Systems Market

  • 15.1. Western Europe Perfusion Systems Market Overview
  • 15.2. Western Europe Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Perfusion Systems Market

  • 16.1. UK Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Perfusion Systems Market

  • 17.1. Germany Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Perfusion Systems Market

  • 18.1. France Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Perfusion Systems Market

  • 19.1. Italy Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Perfusion Systems Market

  • 20.1. Spain Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Perfusion Systems Market

  • 21.1. Eastern Europe Perfusion Systems Market Overview
  • 21.2. Eastern Europe Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Perfusion Systems Market

  • 22.1. Russia Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Perfusion Systems Market

  • 23.1. North America Perfusion Systems Market Overview
  • 23.2. North America Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Perfusion Systems Market

  • 24.1. USA Perfusion Systems Market Overview
  • 24.2. USA Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Perfusion Systems Market

  • 25.1. Canada Perfusion Systems Market Overview
  • 25.2. Canada Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Perfusion Systems Market

  • 26.1. South America Perfusion Systems Market Overview
  • 26.2. South America Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Perfusion Systems Market

  • 27.1. Brazil Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Perfusion Systems Market

  • 28.1. Middle East Perfusion Systems Market Overview
  • 28.2. Middle East Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Perfusion Systems Market

  • 29.1. Africa Perfusion Systems Market Overview
  • 29.2. Africa Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Perfusion Systems Market Competitive Landscape And Company Profiles

  • 30.1. Perfusion Systems Market Competitive Landscape
  • 30.2. Perfusion Systems Market Company Profiles
    • 30.2.1. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Lifeline Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Perfusion Systems Market Other Major And Innovative Companies

  • 31.1. XVIVO Perfusion AB
  • 31.2. Repligen Corporation
  • 31.3. Spectrum Laboratories Inc.
  • 31.4. Merck KGaA
  • 31.5. Harvard Bioscience Inc.
  • 31.6. ALA Scientific Instruments Inc.
  • 31.7. XENIOS AG
  • 31.8. Siemens Healthcare Private Limited
  • 31.9. Shimadzu Corporation
  • 31.10. GENERAL ELECTRIC COMPANY
  • 31.11. Organ Assist Products B.V.
  • 31.12. Hitachi Ltd.
  • 31.13. Bioptechs Inc.
  • 31.14. Cytiva Company
  • 31.15. Sorin Group

32. Global Perfusion Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Perfusion Systems Market

34. Recent Developments In The Perfusion Systems Market

35. Perfusion Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Perfusion Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Perfusion Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Perfusion Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer